InvestorsHub Logo

Know-Fear

02/15/22 8:13 PM

#444255 RE: flipper44 #444250

But….but…..but, I have never sat through a PowerPoint presentation where the presenter shaded information about a competitor

Dr Bala

02/15/22 8:42 PM

#444259 RE: flipper44 #444250

Not surprised by the antics.

dennisdave

02/16/22 3:29 AM

#444299 RE: flipper44 #444250

wow so they are not only lying to investors about NWBO trial results on April 9, 2021 when NWBO was probably not even unblinded or just unblinded, with very specific data but also misleading investors about their own trial?


Has no one learned anything from the Elizabeth Holmes lawsuit?

flipper44

02/16/22 12:02 PM

#444395 RE: flipper44 #444250

Correction, I forgot Aivita recently, as I assumed they would, announced failure regarding overall survival in their phase ii trial.

https://jitc.bmj.com/content/9/Suppl_2/A1001

OS was 72% at 12 months, but dropped to 54% at 14.6 months; median OS is 16.0 months.



PFS was very encouraging but did not translate into OS….